Do insulinotropic glucose-lowering drugs do more harm than good? The hypersecretion hypothesis revisited
Author:
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00125-010-1839-0.pdf
Reference50 articles.
1. Pfeiffer EF, Schoffling K, Steigerwald H, Treser G, Otto M (1957) Problem of secondary failure in the oral treatment of diabetes mellitus. Dtsch Med Wochenschr 82:1528–1531 (article in German)
2. Groop LC, Pelkonen R, Koskimies S, Bottazzo GF, Doniach D (1986) Secondary failure to treatment with oral antidiabetic agents in non-insulin-dependent diabetes. Diab Care 9:129–133
3. U.K. Prospective Diabetes Study Group (1995) U.K. prospective diabetes study 16. Overview of 6 years’ therapy of type II diabetes: a progressive disease. Diabetes 44:1249–1258
4. Turner RC, Cull CA, Frighi V, Holman RR (1999) Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 281:2005–2012
5. van Haeften TW (2002) Early disturbances in insulin secretion in the development of type 2 diabetes mellitus. Mol Cell Endocrinol 197:197–204
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Telmisartan Potentiates Insulin Secretion via Ion Channels, Independent of the AT1 Receptor and PPARγ;Frontiers in Pharmacology;2021-09-14
2. Telmisartan potentiates insulin secretion via ion channels, independent of the AT1 receptor and PPARγ;2020-09-20
3. Improving glycaemic control in type 2 diabetes: S timulate insulin secretion or provide beta‐cell rest?;Diabetes, Obesity and Metabolism;2017-07-10
4. Gliclazide may have an antiapoptotic effect related to its antioxidant properties in human normal and cancer cells;Molecular Biology Reports;2011-12-20
5. Erfordern neue biochemische Befunde ein Umdenken bei der Therapie des Typ-2-Diabetes?;Diabetologie und Stoffwechsel;2011-06-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3